These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31831161)

  • 61. Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo.
    van Ogtrop ML; Mattie H; Guiot HF; van Strijen E; Sekh BR; van Furth R
    Antimicrob Agents Chemother; 1991 Mar; 35(3):417-22. PubMed ID: 2039191
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New β-lactam - Tetramic acid hybrids show promising antibacterial activities.
    Cherian PT; Cheramie MN; Marreddy RKR; Fernando DM; Hurdle JG; Lee RE
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3105-3112. PubMed ID: 30097368
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro antibacterial activities of p-toluenesulfonyl-hydrazinothiazoles and hydrazinoselenazoles against multi-drug resistant Gram-negative phenotypes.
    Mbaveng AT; Ignat AG; Ngameni B; Zaharia V; Ngadjui BT; Kuete V
    BMC Pharmacol Toxicol; 2016 Jan; 17():3. PubMed ID: 26782344
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
    Wang Y; Zhang Q; Jin Y; Jin X; Yu J; Wang K
    Braz J Microbiol; 2019 Jul; 50(3):669-675. PubMed ID: 30972583
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.
    Castanheira M; Mills JC; Costello SE; Jones RN; Sader HS
    Antimicrob Agents Chemother; 2015; 59(6):3509-17. PubMed ID: 25845862
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A new class of cis-monobactam derivatives bearing a sulfamoyloxymethyl or an N-alkylsulfamoyloxymethyl group at position 4: synthesis and antibacterial activity.
    Guanti G; Riva R; Cascio G; Manghisi E; Morandotti G; Satta G; Sperning R
    Farmaco; 1998 Mar; 53(3):173-80. PubMed ID: 9639865
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
    Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
    Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
    Blahová J; Hupková M; Králiková K; Krcméry V; Lísková A; Kubonová K
    Zentralbl Bakteriol; 1998 Jul; 288(1):75-86. PubMed ID: 9728407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Size Matters and How You Measure It: A Gram-Negative Antibacterial Example Exceeding Typical Molecular Weight Limits.
    Ruggiu F; Yang S; Simmons RL; Casarez A; Jones AK; Li C; Jansen JM; Moser HE; Dean CR; Reck F; Lindvall M
    ACS Infect Dis; 2019 Oct; 5(10):1688-1692. PubMed ID: 31478369
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A novel framework to compare the effectiveness of β-lactamase inhibitors against extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Abodakpi H; Chang KT; Zhou J; Byerly C; Tam VH
    Clin Microbiol Infect; 2019 Sep; 25(9):1154.e9-1154.e14. PubMed ID: 30664934
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
    Alatoom A; Elsayed H; Lawlor K; AbdelWareth L; El-Lababidi R; Cardona L; Mooty M; Bonilla MF; Nusair A; Mirza I
    Int J Infect Dis; 2017 Sep; 62():39-43. PubMed ID: 28610832
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens.
    Ma CX; Lv W; Li YX; Fan BZ; Han X; Kong FS; Tian JC; Cushman M; Liang JH
    Eur J Med Chem; 2019 May; 169():1-20. PubMed ID: 30852383
    [TBL] [Abstract][Full Text] [Related]  

  • 75. N-heterocyclic dicarboxylic acids: broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria.
    Feng L; Yang KW; Zhou LS; Xiao JM; Yang X; Zhai L; Zhang YL; Crowder MW
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5185-9. PubMed ID: 22796180
    [TBL] [Abstract][Full Text] [Related]  

  • 76. From Phenylthiazoles to Phenylpyrazoles: Broadening the Antibacterial Spectrum toward Carbapenem-Resistant Bacteria.
    Hammad A; Abutaleb NS; Elsebaei MM; Norvil AB; Alswah M; Ali AO; Abdel-Aleem JA; Alattar A; Bayoumi SA; Gowher H; Seleem MN; Mayhoub AS
    J Med Chem; 2019 Sep; 62(17):7998-8010. PubMed ID: 31369262
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712.
    Chen H; Blizzard TA; Kim S; Wu J; Young K; Park YW; Ogawa AM; Raghoobar S; Painter RE; Wisniewski D; Hairston N; Fitzgerald P; Sharma N; Scapin G; Lu J; Hermes J; Hammond ML
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4267-70. PubMed ID: 21676616
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Design, synthesis and molecular modeling studies of new series of s-triazine derivatives as antimicrobial agents against multi-drug resistant clinical isolates.
    Haiba NS; Khalil HH; Moniem MA; El-Wakil MH; Bekhit AA; Khattab SN
    Bioorg Chem; 2019 Aug; 89():103013. PubMed ID: 31174040
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Strange formation of N-hydroxy-3,3-dimethyl-2,6-diarylpiperidin-4-one and its oxime derivative--synthesis, stereochemistry, antibacterial and antifungal activity.
    Kanagarajan V; Sureshkumar P; Gopalakrishnan M
    Eur Rev Med Pharmacol Sci; 2010 Jul; 14(7):597-604. PubMed ID: 20707249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.